U.S. SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 3
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934,
Section 17(a) of the Public Utility Holding Company Act of 1935 or
Section 30(f) of the Investment Company Act of 1940
================================================================================
1. Name and Address of Reporting Person*
Johnson & Johnson
One Johnson & Johnson Plaza
New Brunswick, New Jersey 08933
ET/FM Acquisition Corp.
c/o Johnson & Johnson
One Johnson & Johnson Plaza
New Brunswick, New Jersey 08933
================================================================================
2. Date of Event Requiring Statement (Month/Day/Year)
10/3/98
================================================================================
3. IRS or Social Security Number of Reporting Person, if an entity (voluntary)
22-1024240
================================================================================
4. Issuer Name and Ticker or Trading Symbol
FemRx, Inc. (FMRX)
================================================================================
5. Relationship of Reporting Person to Issuer
(Check all applicable)
[ ] Director [ x ] 10% Owner
[ ] Officer (give title below) [ ] Other (specify below)
--------------------------------------------------------------------
================================================================================
6. If Amendment, Date of Original (Month/Day/Year)
================================================================================
7. Individual or Joint/Group Filing (Check Applicable Line)
[ ] Form filed by One Reporting Person
[ x ] Form filed by More than One Reporting Person
================================================================================
Table I -- Non-Derivative Securities Beneficially Owned
================================================================================
<TABLE>
<CAPTION>
3. Ownership Form:
2. Amount of Securities Direct (D) or
1. Title of Security Beneficially Owned Indirect (I) 4. Nature of Indirect Beneficial Ownership
(Instr. 4) (Instr. 4) (Instr. 5) (Instr.5)
- ------------------------------------------------------------------------------------------------------------------------------------
<S> <C> <C> <C>
Common Stock, par value $.001 per share 5,179,858 I See note 1 on attached page.
- ------------------------------------------------------------------------------------------------------------------------------------
- ------------------------------------------------------------------------------------------------------------------------------------
- ------------------------------------------------------------------------------------------------------------------------------------
- ------------------------------------------------------------------------------------------------------------------------------------
- ------------------------------------------------------------------------------------------------------------------------------------
====================================================================================================================================
</TABLE>
Reminder: Report on a separate line for each class of securities beneficially
owned directly or indirectly.
* If the Form is filed by more than one Reporting Person, see Instruction
5(b)(v)
Page 1 of 2
<PAGE>
FORM 3 (continued)
Table II -- Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
================================================================================
<TABLE>
<CAPTION>
5. Owner-
3. Title and Amount of Securities ship
Underlying Derivative Security Form of
2. Date Exercisable (Instr. 4) Derivative
and Expiration Date --------------------------------- 4. Conver- Security:
(Month/Day/Year) Amount sion or Direct 6. Nature of
---------------------- or Exercise (D) or Indirect
Date Expira- Number Price of Indirect Beneficial
1. Title of Derivative Exer- tion of Derivative (I) Ownership
Security (Instr. 4) cisable Date Title Shares Security (Instr.5) (Instr. 5)
- ------------------------------------------------------------------------------------------------------------------------------------
<S> <C> <C> <C> <C> <C> <C> <C>
Options to Purchase See note 2 See note 2 Common Stock, par 235,000 $2.9375 I See note 1
Common Stock, par on attached on attached value $.001 per on attached
value $.001 per share page. page. share page.
- ------------------------------------------------------------------------------------------------------------------------------------
- ------------------------------------------------------------------------------------------------------------------------------------
- ------------------------------------------------------------------------------------------------------------------------------------
- ------------------------------------------------------------------------------------------------------------------------------------
- ------------------------------------------------------------------------------------------------------------------------------------
- ------------------------------------------------------------------------------------------------------------------------------------
- ------------------------------------------------------------------------------------------------------------------------------------
- ------------------------------------------------------------------------------------------------------------------------------------
- ------------------------------------------------------------------------------------------------------------------------------------
- ------------------------------------------------------------------------------------------------------------------------------------
- ------------------------------------------------------------------------------------------------------------------------------------
====================================================================================================================================
**Intentional misstatements or omissions of facts constitute Federal Criminal Violations.
See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
/s/ Peter S. Galloway 10/12/98
----------------------------- --------
** Signature of Reporting Person Date
Johnson & Johnson
By: Peter S. Galloway
Note: File three copies of this Form, one of which Title: Secretary
must be manually signed. If space is sufficient,
See Instruction 6 for procedure.
Potential persons who are to respond to the collection
of information contained in this form are not
required to respond unless the form displays a currently /s/ Philip P. Crowley 10/12/98
valid OMB Number. ----------------------------- --------
Signature of Reporting Person Date
ET/FM Acquisition Corp.
By: Philip P. Crowley
Title: Vice President
</TABLE>
<PAGE>
Explanation of Responses
1. On October 3, 1998, in connection with the proposed merger
(the "Merger") of ET/FM Acquisition Corp. (the "Purchaser"), a wholly owned
subsidiary of Johnson & Johnson ("Parent"), with and into FemRx, Inc. (the
"Company"), the Purchaser and Parent have entered into Stockholder
Agreements (the "Stockholder Agreements") with certain stockholders (the
"Stockholders") of the Company. The Stockholders beneficially own 5,414,858
shares of common stock, par value $.001 per share, of the Company (the
"Shares"), including 235,000 Shares issuable upon the exercise of options,
or approximately 59.1% of the Shares outstanding as of September 30, 1998,
based on a representation of the Company in the Agreement and Plan of
Merger dated as of October 3, 1998, among Parent, the Purchaser and the
Company (the "Merger Agreement"). Under the Stockholder Agreements, the
Stockholders have agreed with Parent and the Purchaser to tender to the
Purchaser, pursuant to the Purchaser's tender offer (the "Offer") for all
the outstanding Shares, or sell to the Purchaser immediately following the
Offer, in each case, at a price of $2.35 per Share, all the Shares owned by
the Stockholders. In addition, any Shares that any such Stockholder may
subsequently acquire (by exercise of stock options or otherwise)
automatically become subject to the provisions of the Stockholder
Agreements. If the Purchaser accepts for payment and pays for any Shares
tendered under the Offer, the Purchaser must purchase the Shares subject to
the Stockholder Agreements immediately following the Offer (unless all the
Shares subject to the Stockholder Agreements have been tendered by the
Stockholders and accepted for payment by the Purchaser under the Offer).
Pursuant to the Stockholder Agreements, each Stockholder has also delivered
a proxy to the Purchaser to vote, or grant a consent or approval in respect
of, the Shares subject to the Stockholder Agreements against any
transaction with a third party other than the transactions contemplated by
the Offer and the Merger.
2. Under the Merger Agreement, the options will vest and become
exercisable five business days prior to the earliest date on which the
Purchaser can purchase any Shares pursuant to the Offer (contingent upon
such purchase) and, if not exercised, will be canceled concurrently with
(and contingent upon) the consummation of the Offer.
